Legal & General Q1 2026 13F Holdings and Activity Report

I. Institutional Overview

A defining characteristic of Legal & General’s investment philosophy, as evidenced by its current holdings, is the marriage of extreme diversification with high-conviction core positioning. The institution currently maintains positions in 3,354 individual stocks . This level of breadth suggests a sophisticated multi-strategy approach that likely includes a combination of broad-market index tracking, quantitative factor-based strategies, and active thematic overlays. By holding over three thousand securities, Legal & General effectively captures the "beta" of the global equity markets, ensuring that its portfolio is resilient against idiosyncratic shocks to any single company or niche industry. However, despite this vast number of holdings, the portfolio remains top-heavy, with a significant portion of its total value concentrated in a handful of technology and financial giants. This structure reveals a "core-satellite" psychological portrait: the "core" provides stability and market-matching returns, while the "satellites" and active weight adjustments reflect the institution's tactical views on where the next phase of growth will emerge.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

II. Sector Allocation Analysis

The 32.79% weight in Technology confirms that Legal & General remains a firm believer in the "Digital Transformation" and "AI Revolution" themes. However, a deeper look at the individual holding changes suggests that while they maintain a massive presence in tech, they are no longer blindly adding to it. Instead, they are becoming "valuation-sensitive" within the sector. The high weight in Financials (12.66%) acts as a counterbalance, providing exposure to interest rate environments and global credit cycles. This suggests the institution is positioned for a "higher-for-longer" or at least a "stable-and-elevated" interest rate regime, which typically benefits large-scale financial intermediaries.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

III. Top 10 Holdings Deep Dive

The investment logic for NVDA (NVIDIA Corporation) is rooted in its role as the "arms dealer" for the AI era. As long as hyperscalers and enterprises continue to build out AI infrastructure, NVIDIA’s H100 and Blackwell chips remain essential. However, by trimming the position, Legal & General is acknowledging that the "easy money" from the initial AI surge has been made, and future gains may be more incremental. The reduction also suggests a sensitivity to valuation; at current levels, the market has priced in near-perfection, leaving little room for error in earnings reports. For Legal & General, NVDA (NVIDIA Corporation) is a "conviction holding" that is currently being "milked" for liquidity to fund other strategic areas.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

IV. Major Buys/Additions

The logic behind this massive move is likely two-fold. First, AstraZeneca has emerged as a powerhouse in oncology, rare diseases, and cardiovascular treatments. Its pipeline is considered one of the strongest in the pharmaceutical industry. Second, from a portfolio construction standpoint, this move represents a massive "rotation into quality and defensiveness." By moving $5 billion into a stable, dividend-paying healthcare giant, Legal & General is creating a "buffer" against potential volatility in its tech-heavy core. This is a "Distressed Reversal Bet" or a "Growth at a Reasonable Price (GARP)" play, as AstraZeneca offers high-single-digit or double-digit growth at a valuation much lower than the AI-driven tech stocks. This single operation has transformed AZN (AstraZeneca PLC) from a negligible holding into the 11th largest position in a $431 billion portfolio.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

V. Major Sells and Exits

The logic for a complete exit could be "Valuation Peak" or "Sector Consolidation." Cybersecurity is a highly fragmented and competitive industry. By exiting CyberArk, Legal & General might be signaling that it prefers broader, more diversified tech giants (like Microsoft or Google) to handle security, rather than niche players. Alternatively, after a strong run in cybersecurity stocks, the institution may have decided to "lock in" 100% of its gains and move that capital into the massive AstraZeneca position. This is a classic "Sell A to Buy B" rotation.

Combined, these three trims provided nearly $1.3 billion in liquidity. The logic is "Strategic Rebalancing." These are not "stop-loss" trades; they are "profit-harvesting" trades. Legal & General is using its most successful investments as a "bank" to fund its new $5 billion conviction in AstraZeneca and its additions to healthcare and semiconductor equipment. This reveals a highly disciplined investment process: sell what is expensive and has already performed, and buy what is relatively undervalued or provides necessary diversification.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

VI. Investment Insights and Risk Warnings

For individual investors, the reference value here is the importance of rebalancing . Even the world’s largest institutions do not hold their winners forever; they systematically take profits to ensure their portfolio remains aligned with their risk tolerance. The move into semiconductor hardware (Micron, Lam Research) also suggests that there are still opportunities in tech, but they may be found in the "unsexy" infrastructure providers rather than the "hyped" software names.

This analysis report is for informational and research purposes only and does not constitute investment advice, financial advice, or a recommendation to buy or sell any security. All investment decisions involve risk, including the potential loss of principal. Investors should conduct their own independent research or consult with a qualified financial advisor before making any investment decisions based on the information provided in this report. The author and the data provider are not responsible for any financial losses resulting from the use of this information.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

Sources and limitations

This report uses public U.S. Securities and Exchange Commission Form 13F disclosures and structured data maintained by 13F Hub. A 13F filing is a quarter-end snapshot of reportable long positions, is normally published with a delay, and does not disclose every short position, cash balance, bond, derivative, or non-U.S. asset.

Narrative content is prepared from the same-period SEC disclosure and 13F Hub structured data, then checked before publication. This material is for research and education, not personalized investment advice.